Costs, testing capacity and human resource needs for conducting SARS-CoV-2 surveillance testing across Canada over 14-day intervals
Outcome category | Employees of acute care hospitals | CHW and employees and residents of long-term care facilities | Essential employees with public or interpersonal contact | Children and staff of schools | All groups at once |
---|---|---|---|---|---|
Situation on July 17, 2020 | |||||
Estimated SARS-CoV-2 prevalence in population, % | 0.25 | 0.25 | 0.1 | 0.05 | – |
Total no. of people to sample* | 60 942 | 30 462 | 86 951 | 302 313 | 408 668 |
Human resource requirements | |||||
No. of health care professionals | 73 | 588 | 1235 | 3633 | 5529 |
No. of clerical staff | 145 | 619 | 1322 | 3933 | 6019 |
No. of laboratory staff | 79 | 37 | 107 | 371 | 595 |
Laboratory capacity requirements | |||||
No. of laboratory tests run per day | 4353 | 2176 | 6211 | 21 594 | 34 333 |
Costs to test all, $ | 2.3 million | 6.6 million | 14.4 million | 45.6 million | 69.1 million |
Situation if prevalence was 10 × higher | |||||
Estimated SARS-CoV-2 prevalence in population, % | 2.5 | 2.5 | 1.0 | 0.5 | – |
Total no. of people to sample† | 48 728 | 19 391 | 56 403 | 198 776 | 323 298 |
Human resource requirements | |||||
No. of health care professionals | 58 | 379 | 801 | 2404 | 3642 |
No. of clerical staff | 116 | 399 | 857 | 2601 | 3973 |
No. of laboratory staff | 63 | 24 | 69 | 244 | 401 |
Laboratory capacity requirements | |||||
No. of laboratory tests run per day | 3481 | 1385 | 4029 | 14 198 | 23 093 |
Costs to test all, $ | 1.9 million | 4.3 million | 9.3 million | 30.2 million | 45.7 million |
Note: CHW = community health care workers, SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.
↵* All sample sizes calculated based on having a relative precision of 100% for the 95% confidence interval around the estimated SARS-CoV-2 prevalence.
↵† All sample sizes calculated based on having a relative precision of 50% for the 95% confidence interval around the estimated SARS-CoV-2 prevalence.